[Federal Register Volume 83, Number 73 (Monday, April 16, 2018)]
[Notices]
[Page 16359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07815]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--RFA-CE-18-006, Research 
Grants for the Primary or Secondary Prevention of Opioid Overdose.
    Date: June 27-28, 2018.
    Time: 9:00 a.m.-5:00 p.m., EDT.
    Place: DoubleTree by Hilton Hotel Atlanta--Buckhead, 3342 
Peachtree Road NE, Atlanta, GA 30326.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Dahna Batts, M.D., FACEP, 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Mailstop F-63, Atlanta, Georgia 30341, Telephone (404) 639-2485, 
email [email protected].

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-07815 Filed 4-13-18; 8:45 am]
 BILLING CODE 4163-18-P